Rina Aharoni

Ben-Gurion University of the Negev — Israel

Medicine · Health Sciences

35h-index4.1kcitations100works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(39), Immunotherapy and Immune Responses(30), Neurogenesis and neuroplasticity mechanisms(18), T-cell and B-cell Immunology(17), Neuroinflammation and Neurodegeneration Mechanisms(15)

Publications100 total

Glatiramer Acetate for the Treatment of Multiple Sclerosis: From First-Generation Therapy to Elucidation of Immunomodulation and Repair
Pharmacological Reviews·2024· 4 cited
Repurposing of glatiramer acetate to treat cardiac ischemia in rodent models
Nature Cardiovascular Research·2024· 3 cited
Repurposing of Glatiramer Acetate to Treat Heart Diseases
2023Open Access
Role of Helical Structure in MBP Immunodominant Peptides for Efficient IgM Antibody Recognition in Multiple Sclerosis
Frontiers in Chemistry·2022· 1 citedOpen Access
Immunomodulatory peptidomimetics for multiple sclerosis therapy—the story of glatiramer acetate (Copaxone)
Elsevier eBooks·2022· 2 cited
List of contributors
Elsevier eBooks·2022
Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis
International Journal of Molecular Sciences·2021· 19 citedOpen Access
Astrocytes in Multiple Sclerosis—Essential Constituents with Diverse Multifaceted Functions
International Journal of Molecular Sciences·2021· 70 citedOpen Access
The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5
Nature Communications·2021· 73 citedOpen Access
Titration of myelin oligodendrocyte glycoprotein (MOG) - Induced experimental autoimmune encephalomyelitis (EAE) model
Journal of Neuroscience Methods·2020· 15 cited
Glatiramer acetate increases T- and B -regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis
Journal of Neuroimmunology·2020· 14 cited
Corrigendum to “Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis” [J Neuroimmunol. 2019 Dec 15;337:577070. doi: 10.1016/j.jneuroim.2019.577070. Epub 2019 Oct 24]
Journal of Neuroimmunology·2019
Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis
Journal of Neuroimmunology·2019· 18 cited
Cognitive impairment in an animal model of multiple sclerosis and its amelioration by glatiramer acetate
Scientific Reports·2019· 41 citedOpen Access
<scp>A</scp>strocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis
Glia·2018· 50 citedOpen Access
Can remyelination be enhanced by immunomodulatory therapeutic modality?
Proceedings for Annual Meeting of The Japanese Pharmacological Society·2018Open Access
Erratum: Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae
Scientific Reports·2017· 3 citedOpen Access
The story of glatiramer acetate (copaxone) in the treatment of multiple sclerosis - the potential for neuroprotection by immunomodulatory treatment
Journal of Neurology & Neurophysiology·2017
The story of Copaxone (glatiramer acetate) in the treatment of multiple sclerosis and its new applications
Immunome Research·2017
Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of non-typeable Haemophilus influenzae
Scientific Reports·2016· 30 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Ruth Arnon(36), Michael Sela(22), Raya Eilam(18), Dvora Teitelbaum(11), Ruth Arnon(6), Başak Kayhan(3), A. Meshorer(2), Hagit Domev(2), Galya Labunskay(2), Ariel Stock(2), Anya Vainshtein(2), Elias Shezen(2), Hilah Gal(2), Eric Shifrut(2), Shlomit Reich-Zeliger(2), Nir Friedman(2), D. Teitelbaum(2), Renana From(2), Nofar Schottlender(2), Ori Brenner(2)